Vol 48, No 1 (2010)
Original paper
Submitted: 2011-12-19
Published online: 2010-06-10
Quantitative immunohistochemistry in lung cancer: clinical perspective.
Ewa Szutowicz, Rafał Dziadziuszko
DOI: 10.2478/v10042-010-0014-2
·
Folia Histochem Cytobiol 2010;48(1):7-11.
Vol 48, No 1 (2010)
ORIGINAL PAPERS
Submitted: 2011-12-19
Published online: 2010-06-10
Abstract
Quantitative immunohistochemistry remains an important tool in translational lung cancer research with hopes to improve patient outcomes and avoid unnecessary therapies. Present review is aimed to summarize the use of immunohistochemical markers for improved prognostic information and prediction of treatment benefit. Several of these markers are currently explored in phase II-III clinical studies to individualize the treatment of lung cancer.
Abstract
Quantitative immunohistochemistry remains an important tool in translational lung cancer research with hopes to improve patient outcomes and avoid unnecessary therapies. Present review is aimed to summarize the use of immunohistochemical markers for improved prognostic information and prediction of treatment benefit. Several of these markers are currently explored in phase II-III clinical studies to individualize the treatment of lung cancer.
Title
Quantitative immunohistochemistry in lung cancer: clinical perspective.
Journal
Folia Histochemica et Cytobiologica
Issue
Vol 48, No 1 (2010)
Article type
Original paper
Pages
7-11
Published online
2010-06-10
Page views
3031
Article views/downloads
2313
DOI
10.2478/v10042-010-0014-2
Bibliographic record
Folia Histochem Cytobiol 2010;48(1):7-11.
Authors
Ewa Szutowicz
Rafał Dziadziuszko